# Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion

> **NCT03327272** · PHASE3 · WITHDRAWN · sponsor: **Rush University Medical Center**

## Conditions studied

- Stenosis
- Herniated Nucleus Pulposus
- Degenerative Disc Disease
- Spondylosis
- Myelopathy
- Radiculopathy
- Myeloradiculopathy

## Interventions

- **DRUG:** Methylprednisolone
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT03327272
- **Lead sponsor:** Rush University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-05-22
- **Primary completion:** 2020-07-24
- **Final completion:** 2020-07-24
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Did not enroll, PI decided not to proceed.
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03327272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03327272, "Impact of Local Steroid Application in Extreme Lateral Lumbar Interbody Fusion". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03327272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*